Our studies indicate that with intratumoral administration of NDV, the expression of ICOSL is limited to only a small percentage of cells and is likely short-lived (Fig. 2f; Supplementary Fig. 4), though this appears to be sufficient to enhance anti-tumour effect. Here, ICOSLG is linked to neoplasm.